Vanderbilt University Medical Center: Obesity trials

The registry lists 26 Obesity studies with Vanderbilt University Medical Center as lead sponsor. 7 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 8Phase 2 10Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideNot yet recruitingNCT07760948Phase 2
• Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseNot yet recruitingNCT07760909Not applicable
• Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyNot yet recruitingNCT07642635Phase 1/2
• Transition to Ambulatory Bariatric Surgery (TABS) TrialRecruitingNCT07011628Not applicable
• The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial FunctionRecruitingNCT05972564Phase 1/2
• Sympathetic Mechanisms in Obesity-Crossover DesignRecruitingNCT05312892Phase 1/2
• Physiologic and Functional Adaptations of Insulin Sensitive TissuesEnrolling by invitationNCT03407833
• SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity PilotCompletedNCT04907214Phase 1/2Results posted
• Effect of PDE5 Inhibition on Adipose Metabolism in HumansCompletedNCT04684589Phase 2Results posted
• Visualizing Vascular Mechanisms of Salt SensitivityCompletedNCT03696433Not applicableResults posted
• PDE5 Inhibition for Obesity-Related Cardiometabolic DysfunctionCompletedNCT02819440Phase 2Results posted
• Early-onset Obesity and Cognitive Impairment in Children With PseudohypoparathyroidismCompletedNCT02411461Results posted
• Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain TumorCompletedNCT01484873Phase 2Results posted
• Comparison of Body Composition Changes With Weight Loss InterventionsActive, not recruitingNCT07115069
• GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot TrialActive, not recruitingNCT06162715Phase 2/3
• Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)Active, not recruitingNCT05254314Phase 2
• Competency Based Approaches for Community Health 2Active, not recruitingNCT04971044Not applicable
• Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in ObesityActive, not recruitingNCT03318094Phase 1
• Examination of Cognitive Function in Obesity and Following Weight LossWithdrawnNCT02994186
• Effect of Ghrelin on Glucose Metabolism After Bariatric SurgeryCompletedNCT02953587Phase 1
• Small Bowel Length and Bariatric Surgery OutcomesCompletedNCT02872493
• Natriuretic Peptides and Metabolic Risk in ObesityWithdrawnNCT02642523Early Phase 1
• Role of the Foregut in Nutrient Metabolism in Lean and Obese HumansCompletedNCT02537314Phase 1
• Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal FailureCompletedNCT02128802Not applicable
• Pathophysiology of Cardiometabolic Risk Factors in African AmericansCompletedNCT01122407Phase 1
• The Role of the Omentum in the Treatment of Morbid ObesityCompletedNCT00212160Not applicable